A Multicenter, Randomized, Controlled Trial of Combination Therapy for Lamivudine-Resistant Chronic Hepatitis B Patient: Comparing Clevudine Plus Adefovir With Lamivudine Plus Adefovir.
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Adefovir; Clevudine; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 22 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Feb 2009 Actual initiation date (Dec 2008) added as reported by ClinicalTrials.gov.